- Home
- PACB
as 06-20-2025 3:39pm EST
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | MENLO PARK |
| Market Cap: | 364.2M | IPO Year: | 2010 |
| Target Price: | $2.13 | AVG Volume (30 days): | 10.4M |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.85 - $2.72 | Next Earning Date: | 08-06-2025 |
| Revenue: | $152,357,000 | Revenue Growth: | -23.98% |
| Revenue Growth (this year): | 3.33% | Revenue Growth (next year): | 18.52% |
Stock Insider Trading Activity of Pacific Biosciences of California Inc. (PACB)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Farmer Michele | PACB | See Remarks | May 19 '25 | Sell | $1.00 | 5,195 | $5,200.20 | 269,259 |
Latest Pacific Biosciences of California Inc. News
PACB Breaking Stock News: Dive into PACB Ticker-Specific Updates for Smart Investing
StockStory
3 days ago
3 Stocks Under $10 with Open Questions
Zacks
8 days ago
Why Is Steris (STE) Down 1.8% Since Last Earnings Report?
Zacks
9 days ago
Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know
StockStory
12 days ago
PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market Headwinds
StockStory
17 days ago
Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment
MT Newswires
19 days ago
Pacific Biosciences of California, Target ALS Collaborate for Genomic Study
PR Newswire
20 days ago
Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date
Zacks
23 days ago
All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy
Compare PACB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PACB Pacific Biosciences of California Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.